Mounjaro Takes India’s GLP-1 Market by Storm Like a Champion

Listen up, folks! Mounjaro is dominating the GLP-1 scene in India, raking in a staggering ₹1,256 crore in just 12 months! With a 502% sales boom, injectables are the real MVPs, claiming 86% of the market. Generics are stepping into the ring, but the original champs are still flexing their muscles. The health battle is heating up, and Mounjaro is here to lay the smackdown!